Recent Finacing
Recent Raise
HekaBio is a Japan-based asset-light platform that reviews 200+ assets annually, in-licenses early-stage CNS, oncology and longevity therapies and MedTech, synchronizes US–Japan development, and manages licensing-to-sales across APAC.